APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,623,059 | +403.0% | 226,684 | +1104.6% | 0.03% | +383.3% |
| Q2 2023 | $1,714,320 | +429.3% | 18,818 | +283.3% | 0.01% | +500.0% |
| Q1 2023 | $323,864 | -87.7% | 4,910 | -90.3% | 0.00% | -83.3% |
| Q4 2022 | $2,628,057 | +125.0% | 50,823 | +96.8% | 0.01% | +200.0% |
| Q2 2022 | $1,168,000 | -58.6% | 25,823 | -53.5% | 0.00% | -33.3% |
| Q1 2022 | $2,822,000 | +65.7% | 55,546 | +54.2% | 0.00% | +200.0% |
| Q4 2021 | $1,703,000 | -51.1% | 36,021 | -65.9% | 0.00% | -75.0% |
| Q3 2021 | $3,486,000 | +7014.3% | 105,752 | +6391.8% | 0.00% | – |
| Q3 2020 | $49,000 | +2350.0% | 1,629 | +1529.0% | 0.00% | – |
| Q3 2019 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,130,000 | $119,065,200 | 18.29% |
| EcoR1 Capital, LLC | 10,899,859 | $414,630,636 | 13.99% |
| Ally Bridge Group (NY) LLC | 181,805 | $6,915,862 | 8.12% |
| Avoro Capital Advisors LLC | 11,111,111 | $422,666,662 | 6.59% |
| ACUTA CAPITAL PARTNERS, LLC | 244,484 | $9,300,171 | 6.23% |
| Iron Triangle Partners LP | 880,000 | $33,475,200 | 4.89% |
| Cormorant Asset Management, LP | 2,000,000 | $76,080,000 | 4.44% |
| Octagon Capital Advisors LP | 675,000 | $25,677,000 | 3.94% |
| Logos Global Management LP | 750,000 | $28,530,000 | 3.81% |
| Boxer Capital, LLC | 1,726,000 | $65,657,040 | 3.50% |